Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis

Belimumab is a recombinant human IgG-1λ monoclonal antibody. It inhibits the B-cell activating factor (BAFF) and is approved for patients with systemic lupus erythematosus (SLE) older than five years with positive autoantibody. We aimed to evaluate the role of belimumab in the maintenance phase of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Sanjeev, Budhathoki, Pravash, Adhikari, Yuvraj, Marasini, Anupama, Bhandari, Shakar, Mir, Wasey Ali Yadullahi, Shrestha, Dhan B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760003/
https://www.ncbi.nlm.nih.gov/pubmed/35047277
http://dx.doi.org/10.7759/cureus.20440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760003/
https://www.ncbi.nlm.nih.gov/pubmed/35047277
http://dx.doi.org/10.7759/cureus.20440

Ejemplares similares